Blog

After a decades-long pause, psychedelics are once again being investigated for their transdiagnostic treatment potential. Discover the future of psychedelics in neurosurgery and neuro-oncology with experts from Pacific Neuroscience Institute ® (PNI).

PNI surgeons demonstrate outstanding outcomes with minimally invasive keyhole surgery for meningioma brain tumors, in groundbreaking 13-year study.

A recent Pacific Neuroscience Institute (PNI) publication may help neurosurgeons to apply less invasive techniques in brain tumor removal.

During COVID-19, Pacific Neuroscience Institute sets new standard of safe, efficient, high quality minimally invasive brain tumor surgery. Find out more.

Pacific Neuroscience Institute at Providence Saint John’s Strives to Set a New Standard in Landmark 10-year Study in over 500 Patients with Focus on Complication Avoidance. Findings published in this month’s “Pituitary” journal SANTA MONICA, Calif., July 8, 2021— Intense focus on avoiding complications in...

PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved.  We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...

An excellent team of outstanding neurosurgeons at Pacific Neuroscience Institute’s Brain Tumor Center has reported on 129 minimally invasive supraorbital (SO) surgeries in a recent paper; the highly encouraging results of a retrospective study are discussed. Minimally Invasive Surgery for Removal of Brain and Skull...

Neurodegenerative disease is a broad term for a range of conditions which mostly affect neurons in the human brain. Currently, 5 million Americans suffer from Alzheimer's disease; 1 million from Parkinson's disease; and 30,000 from Huntington's disease.

A recently published paper by Pacific Neuroscience Institute researchers suggests a promising new approach for a biopsy-free method to identify primary brain tumor genetics for personalized treatment options.

Nanotechnology is a compelling new drug delivery method in oncology where nanoparticles are engineered to target therapeutics to kill cancer. Find out more in Dr. Venkata Yenugonda's review article in the March 2019 issue International Journal of Nanomedicine.